Morgan Stanley’s Immunomedics Inc IMMU Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-193,328
| Closed | -$16.4M | – | 7269 |
|
|
2020
Q3 | $16.4M | Sell |
193,328
-62,307
| -24% | -$3.15M | ﹤0.01% | 1624 |
|
|
2020
Q2 | $9.06M | Sell |
255,635
-65,487
| -20% | -$1.91M | ﹤0.01% | 2064 |
|
|
2020
Q1 | $4.33M | Sell |
321,122
-368,259
| -53% | -$6.2M | ﹤0.01% | 2601 |
|
|
2019
Q4 | $14.6M | Buy |
689,381
+400,319
| +138% | +$7.06M | ﹤0.01% | 1975 |
|
|
2019
Q3 | $3.83M | Buy |
289,062
+169,355
| +141% | +$2.49M | ﹤0.01% | 3160 |
|
|
2019
Q2 | $1.66M | Sell |
119,707
-88,088
| -42% | -$1.33M | ﹤0.01% | 3918 |
|
|
2019
Q1 | $3.99M | Sell |
207,795
-380,639
| -65% | -$6.14M | ﹤0.01% | 2927 |
|
|
2018
Q4 | $8.4M | Buy |
588,434
+62,478
| +12% | +$1.24M | ﹤0.01% | 2308 |
|
|
2018
Q3 | $11M | Sell |
525,956
-43,622
| -8% | -$1.03M | ﹤0.01% | 2314 |
|
|
2018
Q2 | $13.5M | Buy |
569,578
+42,381
| +8% | +$852K | ﹤0.01% | 2043 |
|
|
2018
Q1 | $7.7M | Sell |
527,197
-152,233
| -22% | -$2.49M | ﹤0.01% | 2601 |
|
|
2017
Q4 | $11M | Buy |
679,430
+240,010
| +55% | +$2.83M | ﹤0.01% | 2312 |
|
|
2017
Q3 | $6.14M | Buy |
439,420
+244,029
| +125% | +$2.43M | ﹤0.01% | 2740 |
|
|
2017
Q2 | $1.73M | Sell |
195,391
-171,515
| -47% | -$1.2M | ﹤0.01% | 3934 |
|
|
2017
Q1 | $2.37M | Sell |
366,906
-51,600
| -12% | -$261K | ﹤0.01% | 3658 |
|
|
2016
Q4 | $1.54M | Buy |
418,506
+373,238
| +825% | +$1.1M | ﹤0.01% | 4145 |
|
|
2016
Q3 | $148K | Sell |
45,268
-9,444
| -17% | -$26.4K | ﹤0.01% | 5142 |
|
|
2016
Q2 | $126K | Buy |
54,712
+21,513
| +65% | +$71.9K | ﹤0.01% | 5143 |
|
|
2016
Q1 | $84K | Sell |
33,199
-38,406
| -54% | -$86.4K | ﹤0.01% | 5391 |
|
|
2015
Q4 | $219K | Buy |
71,605
+17,837
| +33% | +$49.8K | ﹤0.01% | 5045 |
|
|
2015
Q3 | $92K | Sell |
53,768
-77,453
| -59% | -$198K | ﹤0.01% | 5459 |
|
|
2015
Q2 | $532K | Buy |
131,221
+59,872
| +84% | +$245K | ﹤0.01% | 4679 |
|
|
2015
Q1 | $273K | Sell |
71,349
-108,482
| -60% | -$472K | ﹤0.01% | 5039 |
|
|
2014
Q4 | $863K | Buy |
179,831
+114,722
| +176% | +$454K | ﹤0.01% | 4268 |
|
|
2014
Q3 | $243K | Sell |
65,109
-33,563
| -34% | -$113K | ﹤0.01% | 5039 |
|
|
2014
Q2 | $360K | Buy |
98,672
+1,358
| +1% | +$4.99K | ﹤0.01% | 4821 |
|
|
2014
Q1 | $409K | Sell |
97,314
-8,611
| -8% | -$42.7K | ﹤0.01% | 4699 |
|
|
2013
Q4 | $488K | Buy |
105,925
+41,398
| +64% | +$184K | ﹤0.01% | 4463 |
|
|
2013
Q3 | $400K | Buy |
64,527
+7,196
| +13% | +$41.4K | ﹤0.01% | 4482 |
|
|
2013
Q2 | $312K | Buy |
+57,331
| New | +$188K | ﹤0.01% | 4580 |
|
Morgan Stanley's IMMU Position: Q4 2020 in Review
Morgan Stanley sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 193,328 shares — an estimated $16.4M sold.
Morgan Stanley first reported a position in IMMU in Q2 2013 and held it in 30 quarters. The position peaked at $16.4M in Q3 2020. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.
- Morgan Stanley reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
- Morgan Stanley sold 193,328 Immunomedics Inc shares in Q4 2020, an estimated $16.4M.
- Morgan Stanley first reported a position in Immunomedics Inc in Q2 2013 and held it in 30 quarters.
- Morgan Stanley's Immunomedics Inc position peaked at $16.4M in Q3 2020.
- 0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.
Based on Morgan Stanley's 13F filing for Q4 2020, filed 16 Feb 2021.